• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项在实际交通中进行的公路驾驶研究的汇总分析,测量血液酒精浓度为0.5 g/L时驾驶过程中横向位置的标准差(即“摆动”)。

A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.

作者信息

Jongen S, Vermeeren A, van der Sluiszen N N J J M, Schumacher M B, Theunissen E L, Kuypers K P C, Vuurman E F P M, Ramaekers J G

机构信息

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 40, 6200 MD, Maastricht, The Netherlands.

Federal Highway Research Institute (BASt), Section U3/Traffic Psychology, Traffic Education, Bruederstrasse 53, D-51427, Bergisch Gladbach, Germany.

出版信息

Psychopharmacology (Berl). 2017 Mar;234(5):837-844. doi: 10.1007/s00213-016-4519-z. Epub 2017 Jan 9.

DOI:10.1007/s00213-016-4519-z
PMID:28070617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5306436/
Abstract

INTRODUCTION

The on-the-road highway driving test is generally regarded as a gold standard for assessing drug-induced driving impairment. The primary outcome measure is the standard deviation of lateral position (SDLP), a measure of road tracking error or "weaving". The test has been calibrated for incremental doses of alcohol almost 30 years ago in order to define the impact of drug-induced impairment in terms of blood alcohol concentration (BAC) equivalents. Drug-induced changes in SDLP exceeding 2.4 cm have been evaluated as clinically relevant ever since. The present analysis was conducted to assess the robustness of the alcohol effect in a range of on-the-road driving studies which have been conducted since the initial alcohol calibration study.

METHODS

The present study pooled data of 182 participants from nine placebo-controlled crossover studies who performed the highway driving test, while their BAC was at or just below the legal limit for drivers (i.e., 0.5 g/L).

RESULTS

Overall, mean SDLP increased with 2.5 cm (95% CI 2.0-2.9 cm). Equivalence testing showed that the clinical relevance criterion value of 2.4 cm fell well within the 95% CI in each individual study. Gender did not affect alcohol-induced changes in SDLP.

DISCUSSION

These results demonstrate the robustness and validity of the clinical relevance criterion for SDLP as measured during on-the-road driving.

摘要

引言

公路驾驶测试通常被视为评估药物所致驾驶能力损害的金标准。主要结局指标是横向位置标准差(SDLP),这是一种衡量道路跟踪误差或“摆动”的指标。近30年前,该测试已针对酒精递增剂量进行了校准,以便根据血液酒精浓度(BAC)当量来界定药物所致损害的影响。从那时起,SDLP药物诱导变化超过2.4厘米就被评估为具有临床相关性。本次分析旨在评估自最初的酒精校准研究以来进行的一系列公路驾驶研究中酒精效应的稳健性。

方法

本研究汇总了来自9项安慰剂对照交叉研究的182名参与者的数据,这些参与者在BAC处于或略低于驾驶员法定限值(即0.5g/L)时进行了公路驾驶测试。

结果

总体而言,平均SDLP增加了2.5厘米(95%CI为2.0 - 2.9厘米)。等效性检验表明,2.4厘米的临床相关性标准值在每项个体研究的95%CI范围内。性别不影响酒精诱导的SDLP变化。

讨论

这些结果证明了公路驾驶期间测量的SDLP临床相关性标准的稳健性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/3964891e0874/213_2016_4519_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/af20dd4d914d/213_2016_4519_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/3c9730d54639/213_2016_4519_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/ceacbd18a063/213_2016_4519_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/3964891e0874/213_2016_4519_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/af20dd4d914d/213_2016_4519_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/3c9730d54639/213_2016_4519_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/ceacbd18a063/213_2016_4519_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e662/5306436/3964891e0874/213_2016_4519_Fig4_HTML.jpg

相似文献

1
A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.一项在实际交通中进行的公路驾驶研究的汇总分析,测量血液酒精浓度为0.5 g/L时驾驶过程中横向位置的标准差(即“摆动”)。
Psychopharmacology (Berl). 2017 Mar;234(5):837-844. doi: 10.1007/s00213-016-4519-z. Epub 2017 Jan 9.
2
Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.慢性阿片类药物治疗对非癌性疼痛患者实际驾驶表现的影响。
Psychopharmacology (Berl). 2017 Mar;234(6):989-999. doi: 10.1007/s00213-017-4539-3. Epub 2017 Feb 12.
3
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.大麻二酚和 Δ9-四氢大麻酚对驾驶性能的影响:一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2177-2186. doi: 10.1001/jama.2020.21218.
4
Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.用于评估药物对驾驶表现影响的驾驶模拟器的有效性和可靠性。
Psychopharmacology (Berl). 2021 Mar;238(3):775-786. doi: 10.1007/s00213-020-05730-6. Epub 2020 Nov 24.
5
The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.鼻腔内给予艾司氯胺酮(84 毫克)和口服米氮平(30 毫克)对道路驾驶表现的影响:一项双盲、安慰剂对照研究。
Psychopharmacology (Berl). 2017 Nov;234(21):3175-3183. doi: 10.1007/s00213-017-4706-6. Epub 2017 Jul 28.
6
Effects of acute alcohol consumption on measures of simulated driving: A systematic review and meta-analysis.急性酒精摄入对模拟驾驶指标的影响:一项系统评价和荟萃分析。
Accid Anal Prev. 2017 May;102:248-266. doi: 10.1016/j.aap.2017.03.001. Epub 2017 Mar 24.
7
Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.抗抑郁药与驾驶能力受损:来自标准道路测试的实证证据。
J Clin Psychiatry. 2003 Jan;64(1):20-9.
8
On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.使用抗组胺药美喹他嗪和左旋美喹他嗪后,单独及与酒精共同作用下的道路驾驶性能。
Psychopharmacology (Berl). 2016 Sep;233(18):3461-9. doi: 10.1007/s00213-016-4386-7. Epub 2016 Aug 4.
9
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.睡前服用20毫克和40毫克苏沃雷生后次日早晨的道路驾驶性能:一项针对非老年健康志愿者的研究。
Sleep. 2015 Nov 1;38(11):1803-13. doi: 10.5665/sleep.5168.
10
On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.健康老年人睡前服用15毫克和30毫克苏沃雷生后次日上午的道路驾驶性能。
Psychopharmacology (Berl). 2016 Sep;233(18):3341-51. doi: 10.1007/s00213-016-4375-x. Epub 2016 Jul 16.

引用本文的文献

1
Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adults.阿普唑仑对健康正常成年人心理运动表现及模拟驾驶的残余次日效应。
Exp Clin Psychopharmacol. 2025 Apr;33(2):178-188. doi: 10.1037/pha0000746. Epub 2024 Nov 14.
2
Cannabis and Driving in Older Adults.老年人中的大麻与驾驶。
JAMA Netw Open. 2024 Jan 2;7(1):e2352233. doi: 10.1001/jamanetworkopen.2023.52233.
3
Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses.

本文引用的文献

1
On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.使用抗组胺药美喹他嗪和左旋美喹他嗪后,单独及与酒精共同作用下的道路驾驶性能。
Psychopharmacology (Berl). 2016 Sep;233(18):3461-9. doi: 10.1007/s00213-016-4386-7. Epub 2016 Aug 4.
2
Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.午夜服用低剂量舌下含服唑吡坦后次日早晨对高速公路驾驶性能的残留影响。
Sleep. 2014 Mar 1;37(3):489-96. doi: 10.5665/sleep.3482.
3
Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.
THC 和乙醇对自我报告能力和模拟驾驶、主观效应以及心血管反应的交互作用的初步研究。
Psychopharmacology (Berl). 2023 Jun;240(6):1235-1246. doi: 10.1007/s00213-023-06356-0. Epub 2023 Apr 12.
4
Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation.适合于道路驾驶和模拟驾驶:一项使用睡眠剥夺效果的随机交叉研究。
PLoS One. 2023 Feb 2;18(2):e0278300. doi: 10.1371/journal.pone.0278300. eCollection 2023.
5
Effects of solriamfetol on on-the-road driving in participants with narcolepsy: A randomised crossover trial.索里昂对发作性睡病患者道路驾驶的影响:一项随机交叉试验。
Hum Psychopharmacol. 2023 Jan;38(1):e2858. doi: 10.1002/hup.2858. Epub 2022 Nov 24.
6
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.索里昂®对阻塞性睡眠呼吸暂停相关日间嗜睡患者道路驾驶表现的影响。
Hum Psychopharmacol. 2022 Nov;37(6):e2845. doi: 10.1002/hup.2845. Epub 2022 May 28.
7
Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia.比较嗜睡症和特发性嗜睡症患者客观清醒和警觉测试与道路驾驶表现。
J Sleep Res. 2022 Jun;31(3):e13518. doi: 10.1111/jsr.13518. Epub 2021 Nov 9.
8
An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.探索长期使用苯二氮䓬类药物的个体在驾驶表现和神经认知方面差异的方法。
Hum Psychopharmacol. 2021 Jul;36(4):e2778. doi: 10.1002/hup.2778. Epub 2021 Feb 6.
9
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.大麻二酚和 Δ9-四氢大麻酚对驾驶性能的影响:一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2177-2186. doi: 10.1001/jama.2020.21218.
10
Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.用于评估药物对驾驶表现影响的驾驶模拟器的有效性和可靠性。
Psychopharmacology (Berl). 2021 Mar;238(3):775-786. doi: 10.1007/s00213-020-05730-6. Epub 2020 Nov 24.
计算并报告效应量以促进累积科学:t检验和方差分析实用入门指南
Front Psychol. 2013 Nov 26;4:863. doi: 10.3389/fpsyg.2013.00863.
4
A review of alcohol-impaired driving: the role of blood alcohol concentration and complexity of the driving task.酒精影响下驾驶的综述:血液酒精浓度的作用及驾驶任务的复杂性
J Forensic Sci. 2013 Sep;58(5):1238-1250. doi: 10.1111/1556-4029.12227. Epub 2013 Jul 23.
5
A maximally selected test of symmetry about zero.关于零点的最大对称性检验。
Stat Med. 2012 Nov 20;31(26):3178-91. doi: 10.1002/sim.5384. Epub 2012 Jun 22.
6
National Highway Traffic Safety Administration (NHTSA) notes. Drugged driving expert panel report: a consensus protocol for assessing the potential of drugs to impair driving.美国国家公路交通安全管理局(NHTSA)指出。药物影响驾驶专家小组报告:评估药物影响驾驶可能性的共识协议。
Ann Emerg Med. 2012 Apr;59(4):323-4.
7
Guidelines for research on drugged driving.药物驾驶研究指南。
Addiction. 2008 Aug;103(8):1258-68. doi: 10.1111/j.1360-0443.2008.02277.x.
8
MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.摇头丸与酒精单独及联合使用对实际驾驶表现和精神运动功能的客观及主观测量指标的影响。
Psychopharmacology (Berl). 2006 Sep;187(4):467-75. doi: 10.1007/s00213-006-0434-z. Epub 2006 Jul 8.
9
Residual effects of sleep medication on driving ability.助眠药物对驾驶能力的残留影响。
Sleep Med Rev. 2004 Aug;8(4):309-25. doi: 10.1016/j.smrv.2004.02.001.
10
Residual effects of hypnotics: epidemiology and clinical implications.催眠药物的残留效应:流行病学及临床意义
CNS Drugs. 2004;18(5):297-328. doi: 10.2165/00023210-200418050-00003.